Self-government HPV vaccination programmes in Poland, 2009–2016

Augustynowicz, Anna; Bojar, Iwona; Borowska, Mariola; Bobiński, Krzysztof; Czerw, Aleksandra

doi:10.26444/aaem/109620

Cited by 10 publications

(10 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An example of such a country could be Poland, where vaccination is carried out locally using the budgets of local government units. Analysis of data from local government programs suggests a population coverage of girls aged 10–14 years of 2.05% [ 67 ]. Ninety percent of global CC deaths occur in low- and middle-income countries, which face difficulties in implementing effective prevention programs due to financial shortages and low public awareness.…”

Section: Review Resultsmentioning

confidence: 99%

Cervical Cancer Prophylaxis—State-of-the-Art and Perspectives

Poniewierza¹,

Panek

2022

Healthcare

View full text Add to dashboard Cite

Background: Each year 604,127 new cases of cervical cancer (CC) are diagnosed, and 341,831 individuals die from the disease. It is the fourth most common cancer among women and the fourth most common cause of death from female cancers worldwide. The pathogenesis of CC is associated with human papillomavirus (HPV) infections and consists of several steps involving cell proliferation outside the human body’s control mechanisms. Strategies to prevent CC are based on screening and vaccination. Scope of the Review: The aim of this paper was to collect and analyze the available literature on the issue of CC prevention and the impact of the COVID-19 pandemic on its implementation. For this purpose, PubMed and Google Scholar databases were searched using keywords, such as “cervical cancer”; “HPV”; “prevention”; “prophylaxis”; “vaccination”; “screening” and “COVID-19” in different variations. Only articles published since 2018 were included in the study. Conclusions: Selected European countries have different CC prevention programs funded by national budgets. This translates into observed differences in the risk of death from CC (age-standardized rate Malta = 1.1, Poland = 5.9). COVID-19 pandemic due to disruption of CC screening may exacerbate these differences in the future. To improve the situation, new screening methods, such as p16/Ki67, HPV self-testing, and the use of artificial intelligence in colposcopic assessment, should be disseminated, as well as free HPV vaccination programs implemented in all countries. The search for new solutions is not without significance and entails ultra-sensitive screening tests for risk groups (mRNA E6/E7, SOX1/SOX14), HPV vaccines with shorter dosing schedules, and new therapeutic pathways using nanotheranostics.

show abstract

Section: Review Resultsmentioning

confidence: 99%

Cervical Cancer Prophylaxis—State-of-the-Art and Perspectives

Poniewierza¹,

Panek

2022

Healthcare

View full text Add to dashboard Cite

show abstract

“…As such, there is no central reporting of the vaccination rates in the Polish general population. The most recent study covering the period from 2009 to 2016 examined 1204 local HPV vaccination programs and reported a 2.05% vaccination rate for girls aged 10-14 years nationwide [67]. This is lower than that reported in private health care and far away from rates necessary for the global goal of eliminating CC.…”

Section: Human Papillomavirus Vaccinationmentioning

confidence: 90%

Cervical Cancer Prevention in the Era of the COVID-19 Pandemic

Poniewierza¹,

Panek

2022

Medicina

View full text Add to dashboard Cite

Background and Objectives: Cervical cancer (CC) is the fourth most common cause of cancer-related morbidity and mortality among women worldwide. CC prevention is based on screening and HPV vaccination. The COVID-19 pandemic has caused difficulties in implementing CC-preventative measures. The aim of this study was to collect data on the implementation of CC prophylaxis in Poland provided by public and private health care with a particular focus on the impact of the COVID-19 pandemic and attempt to estimate the level of CC-screening implementation by 2026 under public and private health care. Materials and Methods: Data on the implementation of privately funded (2016–2021) and publicly funded (2014–2021) CC-preventative measures in Poland were examined. The Prophet algorithm, which positions itself as an automatic forecasting procedure and represents a local Bayesian structural time-series model, was used to predict data. The correlation test statistic was based on Pearson’s product moment correlation coefficient and follows a t distribution. An asymptotic confidence interval was given based on Fisher’s Z transform. Results: In 2021, a significantly higher population screening coverage was observed in private health care (71.91%) than in the public system (12.6%). Our estimation assumes that the adverse downward trend of population coverage (pap smear CC screening) in the public system will continue to 5.02% and in the private health system to 67.92% in 2026. Correlation analysis showed that with the increase in the sum of HPV tests and LBC, the percentage of Pap smear coverage in the private healthcare sector decreases r = −0.62, p = 0.260 df = 3, CI = [−0.97, 0.57]. The amount of HPV vaccinations provided in private health care is steadily increasing. Immunization coverage of the population of girls aged 9–18 years under private health care at the end of the observation period was 4.3% (2021). Conclusions: It is necessary to reorganize the public CC-screening system in Poland based on a uniform reporting system for tests performed in both public and private health care using the model of action proposed by us. We recommend the introduction of a national free HPV vaccination program funded by the government and implemented in public and private health care facilities.

show abstract

“…Human papillomavirus to bezosłonkowy wirus o genomie z kolistym DNA, należący do rodziny Papillomavirideae, rodzaju Papillomavirus. Typy wirusa HPV możemy klasyfikować jako wirusy niskiego ryzyka onkologicznego (6,11,40,42,43,44) wysokiego ryzyka onkologicznego (16,18,31,33,35,39, 45, 51, 52, 56, 58) oraz nienowotworowe (1,2,3,4,7,10). Wirusy brodawczaka ludzkiego (HPV), replikując w nabłonku płaskim skóry i błon śluzowych, powodują powstawanie brodawek o różnej morfologii związanej z typem wirusa oraz lokalizacją zakażenia.…”

Section: Wstępunclassified

Vaccination against HPV (Human Papilloma virus) for women - why is it still recommended and not obligatory in Poland?

Dubel¹,

Dubel²,

Ruszel³

et al. 2022

J Educ Health Sport

View full text Add to dashboard Cite

The most common sexually transmitted viral infection in the world is human papillomavirus (HPV). More than 100 types of HPV, both cutaneous and mucosal, have been characterized. Some HPV genotypes are the cause of cancer, which emphasizes the importance of infection prevention, including the use of vaccination against human papilloma virus.The following work aims to emphasize the role of vaccination in the prevention of HPV infection, discuss the transmission routes of this pathogen as well as diagnostics and treatment methods.

show abstract

Self-government HPV vaccination programmes in Poland, 2009–2016

Cited by 10 publications

References 8 publications

Cervical Cancer Prophylaxis—State-of-the-Art and Perspectives

Cervical Cancer Prophylaxis—State-of-the-Art and Perspectives

Cervical Cancer Prevention in the Era of the COVID-19 Pandemic

Vaccination against HPV (Human Papilloma virus) for women - why is it still recommended and not obligatory in Poland?

Contact Info

Product

Resources

About